The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fentanyl Transdermal Patches Market Research Report 2024
Synopsis
The global Fentanyl Transdermal Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Fentanyl transdermal patches are prescription medications used to manage severe, chronic pain. Fentanyl is a powerful synthetic opioid that is much more potent than morphine and is typically reserved for patients who have developed a tolerance to other opioid medications or for those with chronic pain conditions, such as cancer-related pain.
Here are some key features and information about fentanyl transdermal patches:
1. **Transdermal Delivery**: These patches are designed to deliver fentanyl through the skin and into the bloodstream over an extended period, typically lasting 48 to 72 hours. The slow release of the medication helps provide continuous pain relief.
2. **Dosage**: Fentanyl patches come in different dosage strengths, allowing for individualized pain management. Patients are usually started on a lower dose and may have their dosage adjusted based on their response and tolerance.
3. **Application**: The patches are applied to clean, non-irritated skin, typically on the chest, back, upper arm, or side. The skin should be free of cuts, rashes, or other skin conditions. The patch is usually worn for 72 hours before it is replaced with a new one.
4. **Risk of Overdose**: Fentanyl is extremely potent, and using it improperly can lead to overdose and death. Patients must strictly follow their healthcare provider's instructions for dosing and patch application. It is crucial not to cut, chew, or tamper with the patches, as this can release a dangerous amount of fentanyl all at once.
5. **Side Effects**: Common side effects of fentanyl patches may include nausea, constipation, drowsiness, dizziness, and itching at the patch site. These side effects should be discussed with a healthcare provider.
6. **Cautions**: Fentanyl patches are not typically prescribed for acute or short-term pain due to their potency and slow-release nature. They are reserved for chronic pain management and are generally not suitable for opioid-naïve patients.
7. **Special Monitoring**: Patients using fentanyl patches may require close monitoring by a healthcare provider to ensure proper pain control and to watch for signs of misuse or overdose.
8. **Disposal**: Used fentanyl patches must be disposed of properly to prevent accidental exposure. Many healthcare facilities and pharmacies have programs for the safe disposal of used patches.
It's important for patients to have a clear understanding of the risks and benefits of fentanyl patches and to use them exactly as prescribed by their healthcare provider. These patches should not be used by individuals who have not been specifically prescribed this medication, and they should be stored securely to prevent unauthorized use. Misuse of fentanyl can be life-threatening and is a significant concern in the context of the opioid epidemic.
This report aims to provide a comprehensive presentation of the global market for Fentanyl Transdermal Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fentanyl Transdermal Patches.
Report Scope
The Fentanyl Transdermal Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fentanyl Transdermal Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fentanyl Transdermal Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen
The Medicines
Luye Pharm
Segment by Type
12 mcg/h
25 mcg/h
50 mcg/h
75 mcg/h
100 mcg/h
Segment by Application
Relieve Cancer Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fentanyl Transdermal Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fentanyl Transdermal Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Fentanyl Transdermal Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Fentanyl transdermal patches are prescription medications used to manage severe, chronic pain. Fentanyl is a powerful synthetic opioid that is much more potent than morphine and is typically reserved for patients who have developed a tolerance to other opioid medications or for those with chronic pain conditions, such as cancer-related pain.
Here are some key features and information about fentanyl transdermal patches:
1. **Transdermal Delivery**: These patches are designed to deliver fentanyl through the skin and into the bloodstream over an extended period, typically lasting 48 to 72 hours. The slow release of the medication helps provide continuous pain relief.
2. **Dosage**: Fentanyl patches come in different dosage strengths, allowing for individualized pain management. Patients are usually started on a lower dose and may have their dosage adjusted based on their response and tolerance.
3. **Application**: The patches are applied to clean, non-irritated skin, typically on the chest, back, upper arm, or side. The skin should be free of cuts, rashes, or other skin conditions. The patch is usually worn for 72 hours before it is replaced with a new one.
4. **Risk of Overdose**: Fentanyl is extremely potent, and using it improperly can lead to overdose and death. Patients must strictly follow their healthcare provider's instructions for dosing and patch application. It is crucial not to cut, chew, or tamper with the patches, as this can release a dangerous amount of fentanyl all at once.
5. **Side Effects**: Common side effects of fentanyl patches may include nausea, constipation, drowsiness, dizziness, and itching at the patch site. These side effects should be discussed with a healthcare provider.
6. **Cautions**: Fentanyl patches are not typically prescribed for acute or short-term pain due to their potency and slow-release nature. They are reserved for chronic pain management and are generally not suitable for opioid-naïve patients.
7. **Special Monitoring**: Patients using fentanyl patches may require close monitoring by a healthcare provider to ensure proper pain control and to watch for signs of misuse or overdose.
8. **Disposal**: Used fentanyl patches must be disposed of properly to prevent accidental exposure. Many healthcare facilities and pharmacies have programs for the safe disposal of used patches.
It's important for patients to have a clear understanding of the risks and benefits of fentanyl patches and to use them exactly as prescribed by their healthcare provider. These patches should not be used by individuals who have not been specifically prescribed this medication, and they should be stored securely to prevent unauthorized use. Misuse of fentanyl can be life-threatening and is a significant concern in the context of the opioid epidemic.
This report aims to provide a comprehensive presentation of the global market for Fentanyl Transdermal Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fentanyl Transdermal Patches.
Report Scope
The Fentanyl Transdermal Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fentanyl Transdermal Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fentanyl Transdermal Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen
The Medicines
Luye Pharm
Segment by Type
12 mcg/h
25 mcg/h
50 mcg/h
75 mcg/h
100 mcg/h
Segment by Application
Relieve Cancer Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fentanyl Transdermal Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fentanyl Transdermal Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fentanyl Transdermal Patches Market Overview
1.1 Product Overview and Scope of Fentanyl Transdermal Patches
1.2 Fentanyl Transdermal Patches Segment by Type
1.2.1 Global Fentanyl Transdermal Patches Market Value Comparison by Type (2024-2030)
1.2.2 12 mcg/h
1.2.3 25 mcg/h
1.2.4 50 mcg/h
1.2.5 75 mcg/h
1.2.6 100 mcg/h
1.3 Fentanyl Transdermal Patches Segment by Application
1.3.1 Global Fentanyl Transdermal Patches Market Value by Application: (2024-2030)
1.3.2 Relieve Cancer Pain
1.3.3 Other
1.4 Global Fentanyl Transdermal Patches Market Size Estimates and Forecasts
1.4.1 Global Fentanyl Transdermal Patches Revenue 2019-2030
1.4.2 Global Fentanyl Transdermal Patches Sales 2019-2030
1.4.3 Global Fentanyl Transdermal Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fentanyl Transdermal Patches Market Competition by Manufacturers
2.1 Global Fentanyl Transdermal Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fentanyl Transdermal Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fentanyl Transdermal Patches Average Price by Manufacturers (2019-2024)
2.4 Global Fentanyl Transdermal Patches Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fentanyl Transdermal Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fentanyl Transdermal Patches, Product Type & Application
2.7 Fentanyl Transdermal Patches Market Competitive Situation and Trends
2.7.1 Fentanyl Transdermal Patches Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fentanyl Transdermal Patches Players Market Share by Revenue
2.7.3 Global Fentanyl Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fentanyl Transdermal Patches Retrospective Market Scenario by Region
3.1 Global Fentanyl Transdermal Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fentanyl Transdermal Patches Global Fentanyl Transdermal Patches Sales by Region: 2019-2030
3.2.1 Global Fentanyl Transdermal Patches Sales by Region: 2019-2024
3.2.2 Global Fentanyl Transdermal Patches Sales by Region: 2025-2030
3.3 Global Fentanyl Transdermal Patches Global Fentanyl Transdermal Patches Revenue by Region: 2019-2030
3.3.1 Global Fentanyl Transdermal Patches Revenue by Region: 2019-2024
3.3.2 Global Fentanyl Transdermal Patches Revenue by Region: 2025-2030
3.4 North America Fentanyl Transdermal Patches Market Facts & Figures by Country
3.4.1 North America Fentanyl Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fentanyl Transdermal Patches Sales by Country (2019-2030)
3.4.3 North America Fentanyl Transdermal Patches Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fentanyl Transdermal Patches Market Facts & Figures by Country
3.5.1 Europe Fentanyl Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fentanyl Transdermal Patches Sales by Country (2019-2030)
3.5.3 Europe Fentanyl Transdermal Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fentanyl Transdermal Patches Market Facts & Figures by Country
3.6.1 Asia Pacific Fentanyl Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fentanyl Transdermal Patches Sales by Country (2019-2030)
3.6.3 Asia Pacific Fentanyl Transdermal Patches Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fentanyl Transdermal Patches Market Facts & Figures by Country
3.7.1 Latin America Fentanyl Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fentanyl Transdermal Patches Sales by Country (2019-2030)
3.7.3 Latin America Fentanyl Transdermal Patches Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fentanyl Transdermal Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Fentanyl Transdermal Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fentanyl Transdermal Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fentanyl Transdermal Patches Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fentanyl Transdermal Patches Sales by Type (2019-2030)
4.1.1 Global Fentanyl Transdermal Patches Sales by Type (2019-2024)
4.1.2 Global Fentanyl Transdermal Patches Sales by Type (2025-2030)
4.1.3 Global Fentanyl Transdermal Patches Sales Market Share by Type (2019-2030)
4.2 Global Fentanyl Transdermal Patches Revenue by Type (2019-2030)
4.2.1 Global Fentanyl Transdermal Patches Revenue by Type (2019-2024)
4.2.2 Global Fentanyl Transdermal Patches Revenue by Type (2025-2030)
4.2.3 Global Fentanyl Transdermal Patches Revenue Market Share by Type (2019-2030)
4.3 Global Fentanyl Transdermal Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fentanyl Transdermal Patches Sales by Application (2019-2030)
5.1.1 Global Fentanyl Transdermal Patches Sales by Application (2019-2024)
5.1.2 Global Fentanyl Transdermal Patches Sales by Application (2025-2030)
5.1.3 Global Fentanyl Transdermal Patches Sales Market Share by Application (2019-2030)
5.2 Global Fentanyl Transdermal Patches Revenue by Application (2019-2030)
5.2.1 Global Fentanyl Transdermal Patches Revenue by Application (2019-2024)
5.2.2 Global Fentanyl Transdermal Patches Revenue by Application (2025-2030)
5.2.3 Global Fentanyl Transdermal Patches Revenue Market Share by Application (2019-2030)
5.3 Global Fentanyl Transdermal Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Janssen
6.1.1 Janssen Corporation Information
6.1.2 Janssen Description and Business Overview
6.1.3 Janssen Fentanyl Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Janssen Fentanyl Transdermal Patches Product Portfolio
6.1.5 Janssen Recent Developments/Updates
6.2 The Medicines
6.2.1 The Medicines Corporation Information
6.2.2 The Medicines Description and Business Overview
6.2.3 The Medicines Fentanyl Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 The Medicines Fentanyl Transdermal Patches Product Portfolio
6.2.5 The Medicines Recent Developments/Updates
6.3 Luye Pharm
6.3.1 Luye Pharm Corporation Information
6.3.2 Luye Pharm Description and Business Overview
6.3.3 Luye Pharm Fentanyl Transdermal Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Luye Pharm Fentanyl Transdermal Patches Product Portfolio
6.3.5 Luye Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fentanyl Transdermal Patches Industry Chain Analysis
7.2 Fentanyl Transdermal Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fentanyl Transdermal Patches Production Mode & Process
7.4 Fentanyl Transdermal Patches Sales and Marketing
7.4.1 Fentanyl Transdermal Patches Sales Channels
7.4.2 Fentanyl Transdermal Patches Distributors
7.5 Fentanyl Transdermal Patches Customers
8 Fentanyl Transdermal Patches Market Dynamics
8.1 Fentanyl Transdermal Patches Industry Trends
8.2 Fentanyl Transdermal Patches Market Drivers
8.3 Fentanyl Transdermal Patches Market Challenges
8.4 Fentanyl Transdermal Patches Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
